JTC Inc. (KOSDAQ:950170)

Checkpoint Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is March - February.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2025	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Cash & Equivalents	65,189	71,778	39,919	37,871	24,874	43,836
Short-Term Investments	8,723	7,996	509.08	1,182	3,857	8,206
Cash & Short-Term Investments	73,912	79,775	40,428	39,054	28,731	52,042
Cash Growth	45.92%	97.33%	3.52%	35.93%	-44.79%	-43.63%
Accounts Receivable	16,155	9,503	9,201	2,943	1,100	1,613
Other Receivables	8,170	5,551	8,876	2,310	1,165	1,852
Receivables	25,220	15,948	18,851	6,095	3,176	8,792
Inventory	33,156	32,411	39,643	34,007	34,194	54,261
Prepaid Expenses	2,178	1,734	1,416	1,355	1,392	1,704
Other Current Assets	9,822	5,201	2,068	4,854	2,959	14,233
Total Current Assets	144,288	135,069	102,406	85,365	70,453	131,031
Property, Plant & Equipment	140,286	140,427	115,662	130,108	145,650	197,805
Long-Term Investments	104.82	104.08	92.24	96.05	781.78	770.95
Other Intangible Assets	217.84	229.42	153.32	274.22	154.35	269.72
Long-Term Accounts Receivable	779.4	850.72	218.44	355.34	705.05	1,016
Long-Term Deferred Tax Assets	31,998	35,116	-	-	-	-
Other Long-Term Assets	32,999	33,489	37,388	39,064	41,369	32,904
Total Assets	363,543	358,398	264,357	265,295	270,811	376,344
Accounts Payable	7,683	6,269	5,571	2,207	477.48	629.38
Accrued Expenses	3,182	3,921	1,875	1,329	823.32	1,214
Short-Term Debt	2,730	2,961	13,364	15,164	26,151	21,536
Current Portion of Leases	13,690	13,974	13,686	15,963	18,267	12,185
Current Income Taxes Payable	-	-	-	-	-	4,654
Current Unearned Revenue	-	-	-	-	-	100.46
Other Current Liabilities	22,921	16,176	14,770	12,746	18,478	11,770
Total Current Liabilities	50,206	43,300	49,266	47,410	64,196	52,088
Long-Term Debt	9,294	10,007	7,673	6,606	10,609	18,004
Long-Term Leases	109,971	113,353	117,211	135,334	154,803	172,616
Other Long-Term Liabilities	3,403	3,238	3,205	4,208	4,363	4,261
Total Liabilities	173,863	175,209	182,453	198,555	239,499	252,310
Common Stock	959	962	889	72,348	50,589	50,638
Additional Paid-In Capital	78,065	78,309	65,956	71,743	49,776	49,824
Retained Earnings	63,204	55,928	-24,320	-74,603	-65,613	26,635
Comprehensive Income & Other	47,453	47,990	43,255	209.13	-635.11	-639.01
Total Common Equity	189,680	183,189	85,780	69,697	34,117	126,458
Minority Interest	-	-	-3,876	-2,958	-2,805	-2,423
Shareholders' Equity	189,680	183,189	81,904	66,739	31,312	124,035
Total Liabilities & Equity	363,543	358,398	264,357	265,295	270,811	376,344
Total Debt	135,685	140,295	151,934	173,067	209,829	224,341
Net Cash (Debt)	-61,773	-60,521	-111,506	-134,013	-181,098	-172,299
Net Cash Per Share	-1184.30	-1173.10	-2205.73	-3489.94	-5173.42	-4922.06
Filing Date Shares Outstanding	51.75	51.75	52.29	50.29	35.01	35.01
Total Common Shares Outstanding	51.75	51.75	52.29	50.29	35.01	35.01
Working Capital	94,082	91,769	53,141	37,955	6,257	78,943
Book Value Per Share	3665.57	3540.14	1640.33	1385.94	974.61	3612.51
Tangible Book Value	189,462	182,960	85,626	69,423	33,963	126,188
Tangible Book Value Per Share	3661.36	3535.70	1637.40	1380.49	970.20	3604.81
Land	8,063	8,811	6,241	5,738	6,228	6,585
Buildings	17,161	16,028	15,360	18,798	19,623	21,152
Machinery	6,581	6,698	6,013	7,016	7,519	7,769
Construction In Progress	2,537	1,005	21.39	23.74	376.46	413.82

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.